世界のドラベ症候群治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Dravet Syndrome Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1961
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、ドラベ症候群治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD））、用途別市場規模（病院薬局、小売薬局、Eコマース、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・ドラベ症候群治療の市場動向
・企業の競争状況、市場シェア
・ドラベ症候群治療の種類別市場規模（第一世代薬品（FGD）、第二世代薬品（SGD）、第三世代薬品（TGD））
・ドラベ症候群治療の用途別市場規模（病院薬局、小売薬局、Eコマース、その他）
・ドラベ症候群治療の北米市場規模2016-2027（アメリカ、カナダ）
・ドラベ症候群治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・ドラベ症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ドラベ症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ドラベ症候群治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Biocodex、Epygenix Therapeutics、GW Pharmaceuticals、OPKO Health、Zogenix）
・結論

Dravet syndrome is a rare, severe form of intractable epilepsy. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells.
Although there is no cure for Dravet syndrome, most treatments aim to reduce seizures. First line anti-seizure medications include clobazam (Onfi, Frisium) and valproic acid (Depakote, Depakene). Second line treatments include stiripentol (Diacomit), topiramate (Topamax), and the ketogenic diet.

Market Analysis and Insights: Global Dravet Syndrome Treatment Market
The global Dravet Syndrome Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dravet Syndrome Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dravet Syndrome Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dravet Syndrome Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dravet Syndrome Treatment market.

Global Dravet Syndrome Treatment Scope and Market Size
Dravet Syndrome Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dravet Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
First-generation Drug (FGD)
Second-generation Drug (SGD)
Third-generation Drug (TGD)

Segment by Application
Hospital Pharmacy
Retail Pharmacy
E- Commerce
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biocodex
Epygenix Therapeutics
GW Pharmaceuticals
OPKO Health
Zogenix

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dravet Syndrome Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 First-generation Drug (FGD)
1.2.3 Second-generation Drug (SGD)
1.2.4 Third-generation Drug (TGD)
1.3 Market by Application
1.3.1 Global Dravet Syndrome Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 E- Commerce
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dravet Syndrome Treatment Market Perspective (2016-2027)
2.2 Dravet Syndrome Treatment Growth Trends by Regions
2.2.1 Dravet Syndrome Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dravet Syndrome Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Dravet Syndrome Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Dravet Syndrome Treatment Industry Dynamic
2.3.1 Dravet Syndrome Treatment Market Trends
2.3.2 Dravet Syndrome Treatment Market Drivers
2.3.3 Dravet Syndrome Treatment Market Challenges
2.3.4 Dravet Syndrome Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dravet Syndrome Treatment Players by Revenue
3.1.1 Global Top Dravet Syndrome Treatment Players by Revenue (2016-2021)
3.1.2 Global Dravet Syndrome Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Dravet Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dravet Syndrome Treatment Revenue
3.4 Global Dravet Syndrome Treatment Market Concentration Ratio
3.4.1 Global Dravet Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dravet Syndrome Treatment Revenue in 2020
3.5 Dravet Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Dravet Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Dravet Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dravet Syndrome Treatment Breakdown Data by Type
4.1 Global Dravet Syndrome Treatment Historic Market Size by Type (2016-2021)
4.2 Global Dravet Syndrome Treatment Forecasted Market Size by Type (2022-2027)

5 Dravet Syndrome Treatment Breakdown Data by Application
5.1 Global Dravet Syndrome Treatment Historic Market Size by Application (2016-2021)
5.2 Global Dravet Syndrome Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dravet Syndrome Treatment Market Size (2016-2027)
6.2 North America Dravet Syndrome Treatment Market Size by Type
6.2.1 North America Dravet Syndrome Treatment Market Size by Type (2016-2021)
6.2.2 North America Dravet Syndrome Treatment Market Size by Type (2022-2027)
6.2.3 North America Dravet Syndrome Treatment Market Size by Type (2016-2027)
6.3 North America Dravet Syndrome Treatment Market Size by Application
6.3.1 North America Dravet Syndrome Treatment Market Size by Application (2016-2021)
6.3.2 North America Dravet Syndrome Treatment Market Size by Application (2022-2027)
6.3.3 North America Dravet Syndrome Treatment Market Size by Application (2016-2027)
6.4 North America Dravet Syndrome Treatment Market Size by Country
6.4.1 North America Dravet Syndrome Treatment Market Size by Country (2016-2021)
6.4.2 North America Dravet Syndrome Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Dravet Syndrome Treatment Market Size (2016-2027)
7.2 Europe Dravet Syndrome Treatment Market Size by Type
7.2.1 Europe Dravet Syndrome Treatment Market Size by Type (2016-2021)
7.2.2 Europe Dravet Syndrome Treatment Market Size by Type (2022-2027)
7.2.3 Europe Dravet Syndrome Treatment Market Size by Type (2016-2027)
7.3 Europe Dravet Syndrome Treatment Market Size by Application
7.3.1 Europe Dravet Syndrome Treatment Market Size by Application (2016-2021)
7.3.2 Europe Dravet Syndrome Treatment Market Size by Application (2022-2027)
7.3.3 Europe Dravet Syndrome Treatment Market Size by Application (2016-2027)
7.4 Europe Dravet Syndrome Treatment Market Size by Country
7.4.1 Europe Dravet Syndrome Treatment Market Size by Country (2016-2021)
7.4.2 Europe Dravet Syndrome Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dravet Syndrome Treatment Market Size (2016-2027)
8.2 Asia-Pacific Dravet Syndrome Treatment Market Size by Type
8.2.1 Asia-Pacific Dravet Syndrome Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dravet Syndrome Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dravet Syndrome Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Dravet Syndrome Treatment Market Size by Application
8.3.1 Asia-Pacific Dravet Syndrome Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dravet Syndrome Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dravet Syndrome Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Dravet Syndrome Treatment Market Size by Region
8.4.1 Asia-Pacific Dravet Syndrome Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dravet Syndrome Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dravet Syndrome Treatment Market Size (2016-2027)
9.2 Latin America Dravet Syndrome Treatment Market Size by Type
9.2.1 Latin America Dravet Syndrome Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Dravet Syndrome Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Dravet Syndrome Treatment Market Size by Type (2016-2027)
9.3 Latin America Dravet Syndrome Treatment Market Size by Application
9.3.1 Latin America Dravet Syndrome Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Dravet Syndrome Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Dravet Syndrome Treatment Market Size by Application (2016-2027)
9.4 Latin America Dravet Syndrome Treatment Market Size by Country
9.4.1 Latin America Dravet Syndrome Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Dravet Syndrome Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dravet Syndrome Treatment Market Size (2016-2027)
10.2 Middle East & Africa Dravet Syndrome Treatment Market Size by Type
10.2.1 Middle East & Africa Dravet Syndrome Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dravet Syndrome Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dravet Syndrome Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Dravet Syndrome Treatment Market Size by Application
10.3.1 Middle East & Africa Dravet Syndrome Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dravet Syndrome Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dravet Syndrome Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Dravet Syndrome Treatment Market Size by Country
10.4.1 Middle East & Africa Dravet Syndrome Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dravet Syndrome Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biocodex
11.1.1 Biocodex Company Details
11.1.2 Biocodex Business Overview
11.1.3 Biocodex Dravet Syndrome Treatment Introduction
11.1.4 Biocodex Revenue in Dravet Syndrome Treatment Business (2016-2021)
11.1.5 Biocodex Recent Development
11.2 Epygenix Therapeutics
11.2.1 Epygenix Therapeutics Company Details
11.2.2 Epygenix Therapeutics Business Overview
11.2.3 Epygenix Therapeutics Dravet Syndrome Treatment Introduction
11.2.4 Epygenix Therapeutics Revenue in Dravet Syndrome Treatment Business (2016-2021)
11.2.5 Epygenix Therapeutics Recent Development
11.3 GW Pharmaceuticals
11.3.1 GW Pharmaceuticals Company Details
11.3.2 GW Pharmaceuticals Business Overview
11.3.3 GW Pharmaceuticals Dravet Syndrome Treatment Introduction
11.3.4 GW Pharmaceuticals Revenue in Dravet Syndrome Treatment Business (2016-2021)
11.3.5 GW Pharmaceuticals Recent Development
11.4 OPKO Health
11.4.1 OPKO Health Company Details
11.4.2 OPKO Health Business Overview
11.4.3 OPKO Health Dravet Syndrome Treatment Introduction
11.4.4 OPKO Health Revenue in Dravet Syndrome Treatment Business (2016-2021)
11.4.5 OPKO Health Recent Development
11.5 Zogenix
11.5.1 Zogenix Company Details
11.5.2 Zogenix Business Overview
11.5.3 Zogenix Dravet Syndrome Treatment Introduction
11.5.4 Zogenix Revenue in Dravet Syndrome Treatment Business (2016-2021)
11.5.5 Zogenix Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dravet Syndrome Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of First-generation Drug (FGD)
Table 3. Key Players of Second-generation Drug (SGD)
Table 4. Key Players of Third-generation Drug (TGD)
Table 5. Global Dravet Syndrome Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Dravet Syndrome Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Dravet Syndrome Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Dravet Syndrome Treatment Market Share by Regions (2016-2021)
Table 9. Global Dravet Syndrome Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Dravet Syndrome Treatment Market Share by Regions (2022-2027)
Table 11. Dravet Syndrome Treatment Market Trends
Table 12. Dravet Syndrome Treatment Market Drivers
Table 13. Dravet Syndrome Treatment Market Challenges
Table 14. Dravet Syndrome Treatment Market Restraints
Table 15. Global Dravet Syndrome Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Dravet Syndrome Treatment Market Share by Players (2016-2021)
Table 17. Global Top Dravet Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dravet Syndrome Treatment as of 2020)
Table 18. Ranking of Global Top Dravet Syndrome Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Dravet Syndrome Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dravet Syndrome Treatment Product Solution and Service
Table 22. Date of Enter into Dravet Syndrome Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dravet Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Dravet Syndrome Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Dravet Syndrome Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Dravet Syndrome Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Dravet Syndrome Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Dravet Syndrome Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Dravet Syndrome Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Dravet Syndrome Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Dravet Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Dravet Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Dravet Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Dravet Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Dravet Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Dravet Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Dravet Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Dravet Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Dravet Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Dravet Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Dravet Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Dravet Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Dravet Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Dravet Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Dravet Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Dravet Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Dravet Syndrome Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Dravet Syndrome Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Dravet Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Dravet Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Dravet Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Dravet Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Dravet Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Dravet Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Dravet Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Dravet Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Dravet Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Dravet Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Dravet Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Dravet Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Biocodex Company Details
Table 63. Biocodex Business Overview
Table 64. Biocodex Dravet Syndrome Treatment Product
Table 65. Biocodex Revenue in Dravet Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 66. Biocodex Recent Development
Table 67. Epygenix Therapeutics Company Details
Table 68. Epygenix Therapeutics Business Overview
Table 69. Epygenix Therapeutics Dravet Syndrome Treatment Product
Table 70. Epygenix Therapeutics Revenue in Dravet Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 71. Epygenix Therapeutics Recent Development
Table 72. GW Pharmaceuticals Company Details
Table 73. GW Pharmaceuticals Business Overview
Table 74. GW Pharmaceuticals Dravet Syndrome Treatment Product
Table 75. GW Pharmaceuticals Revenue in Dravet Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 76. GW Pharmaceuticals Recent Development
Table 77. OPKO Health Company Details
Table 78. OPKO Health Business Overview
Table 79. OPKO Health Dravet Syndrome Treatment Product
Table 80. OPKO Health Revenue in Dravet Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 81. OPKO Health Recent Development
Table 82. Zogenix Company Details
Table 83. Zogenix Business Overview
Table 84. Zogenix Dravet Syndrome Treatment Product
Table 85. Zogenix Revenue in Dravet Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 86. Zogenix Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dravet Syndrome Treatment Market Share by Type: 2020 VS 2027
Figure 2. First-generation Drug (FGD) Features
Figure 3. Second-generation Drug (SGD) Features
Figure 4. Third-generation Drug (TGD) Features
Figure 5. Global Dravet Syndrome Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. E- Commerce Case Studies
Figure 9. Others Case Studies
Figure 10. Dravet Syndrome Treatment Report Years Considered
Figure 11. Global Dravet Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Dravet Syndrome Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Dravet Syndrome Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Dravet Syndrome Treatment Market Share by Regions (2022-2027)
Figure 15. Global Dravet Syndrome Treatment Market Share by Players in 2020
Figure 16. Global Top Dravet Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dravet Syndrome Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Dravet Syndrome Treatment Revenue in 2020
Figure 18. Global Dravet Syndrome Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Dravet Syndrome Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Dravet Syndrome Treatment Market Share by Type (2016-2027)
Figure 22. North America Dravet Syndrome Treatment Market Share by Application (2016-2027)
Figure 23. North America Dravet Syndrome Treatment Market Share by Country (2016-2027)
Figure 24. United States Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Dravet Syndrome Treatment Market Share by Type (2016-2027)
Figure 28. Europe Dravet Syndrome Treatment Market Share by Application (2016-2027)
Figure 29. Europe Dravet Syndrome Treatment Market Share by Country (2016-2027)
Figure 30. Germany Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Dravet Syndrome Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Dravet Syndrome Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Dravet Syndrome Treatment Market Share by Region (2016-2027)
Figure 40. China Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Dravet Syndrome Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Dravet Syndrome Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Dravet Syndrome Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Dravet Syndrome Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Dravet Syndrome Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Dravet Syndrome Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Dravet Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Biocodex Revenue Growth Rate in Dravet Syndrome Treatment Business (2016-2021)
Figure 60. Epygenix Therapeutics Revenue Growth Rate in Dravet Syndrome Treatment Business (2016-2021)
Figure 61. GW Pharmaceuticals Revenue Growth Rate in Dravet Syndrome Treatment Business (2016-2021)
Figure 62. OPKO Health Revenue Growth Rate in Dravet Syndrome Treatment Business (2016-2021)
Figure 63. Zogenix Revenue Growth Rate in Dravet Syndrome Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界のドラベ症候群治療市場規模・現状・予測（2021年-2027年）

Global Dravet Syndrome Thereapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z1960 2021年4月 91Pages
QYResearch社発行の本調査資料では、ドラベ症候群治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（BIS-001、カンナビジオール、CUR-1916、SAGE-217、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市...

世界のドラベ症候群治療市場規模・現状・予測（2021年-2027年）

世界のバーター症候群治療市場規模・現状・予測（2021年-2027年）

Global Bartter Syndrome Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0705 2021年4月 93Pages
QYResearch社発行の本調査資料では、バーター症候群治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（NSAID（非ステロイド性抗炎症薬）、RAAS阻害剤、アルドステロン拮抗薬、アンジオテンシンII受容体拮抗薬、アンジオテンシン変換酵素...

世界の多嚢胞性卵巣症候群治療市場規模・現状・予測（2021年-2027年）

Global Polycystic Ovarian Syndrome Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4691 2021年4月 97Pages
QYResearch社発行の本調査資料では、多嚢胞性卵巣症候群治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口避妊薬、インスリン増感剤、抗うつ剤、オルニチン、デカルボキシラーゼ阻害剤、アロマターゼ阻害剤＆SERM、利尿剤）、用途別市場規...

世界のクッシング症候群治療市場規模・現状・予測（2021年-2027年）

Global Cushing's Syndrome Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1679 2021年4月 90Pages
QYResearch社発行の本調査資料では、クッシング症候群治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、...

世界の複合性局所疼痛症候群治療市場規模・現状・予測（2021年-2027年）

Global Complex Regional Pain Syndrome Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1509 2021年4月 96Pages
QYResearch社発行の本調査資料では、複合性局所疼痛症候群治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（T-121、NTRX-07、ネリドロン酸、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリ...

世界の慢性疲労症候群治療市場規模・現状・予測（2021年-2027年）

Global Chronic Fatigue Syndrome Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1312 2021年4月 90Pages
QYResearch社発行の本調査資料では、慢性疲労症候群治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫増強剤・抗ウイルス剤、睡眠増強、CNS（中枢神経系）刺激剤）、用途別市場規模（病院、クリニック、研究機関）、主要地域別市場規模（北...

世界の慢性疲労症候群治療市場規模・現状・予測（2021年-2027年）

世界のクッシング症候群・先端巨大症治療市場規模・現状・予測（2021年-2027年）

Global Cushing's Syndrome and Acromegaly Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1678 2021年4月 95Pages
QYResearch社発行の本調査資料では、クッシング症候群・先端巨大症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）、用途別市場規模（病院薬局、小売薬局、オンラ...

世界のスタージーウェーバー症候群（SWS）治療市場規模・現状・予測（2021年-2027年）

Global Sturge Weber Syndrome (SWS) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5471 2021年4月 94Pages
QYResearch社発行の本調査資料では、スタージーウェーバー症候群（SWS）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（投薬、レーザー治療、手術処置）、用途別市場規模（病院、診療所、診断センター、その他）、主要地域別市場規模（北米、...

世界のドラベ症候群治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Dravet Syndrome Thereapeutics Market The global Dravet Syndrome Thereapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
世界のドラベ症候群治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Dravet Syndrome Thereapeutics Market The global Dravet Syndrome Thereapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
世界の次世代糖尿病治療＆ドラッグデリバリー市場規模・現状・予測（2021年-2027年） Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level. The market growth is attributed to the rise in the number of diabetic patients globally …
世界の多嚢胞性卵巣症候群治療市場規模・現状・予測（2021年-2027年） Polycystic ovary syndrome is a set of symptoms due to elevated androgens in females. Signs and symptoms of polycystic ovary syndrome nclude irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, difficulty getting pregnant and patches of thick, darker, velv…
世界の化学療法薬誘発性肢端紅斑（手足症候群）治療市場規模・現状・予測（2021年-2027年） Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness) and desquamation (skin peeling) of palms, soles and rarely on knees and elbow. Acryl erythema is an adverse drug reaction which typically appear afte…